Due to the limitations of the clinical data, in vitro experimentation was conducted to determine the potential effects of estrogen or PRL on their canonical pathways, including ERα, pERα, PRLR and D2R expression in pituitary adenoma cells. This evidence concerns the gene DRD2 and pituitary gland adenoma.